Ce diaporama a bien été signalé.
Le téléchargement de votre SlideShare est en cours. ×

2022 full-year results highlights

Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Publicité
Prochain SlideShare
Q3 2022 Results
Q3 2022 Results
Chargement dans…3
×

Consultez-les par la suite

1 sur 1 Publicité

Plus De Contenu Connexe

Similaire à 2022 full-year results highlights (20)

Publicité

Plus récents (20)

2022 full-year results highlights

  1. 1. Nikita Khadse, Scientist, R&D, Waltham, Massachusetts Bradd Roberts, Scientist, Analytical Science, Waterford, Ireland With ten consecutive quarters of growth, the progress we’ve made in the past three years speaks for itself. As we launch the next phase of our strategy, our continued commitment to investing in the science will be crucial to maintaining a steady-state cadence of first and best in class medicines. Paul Hudson Chief Executive Officer, Sanofi For further information on full-year 2022 results and definitions of financial indicators, please refer to the press release issued on February 3, 2023 at: www.sanofi.com/en/investors Company sales and business EPS* Sales by global business unit Sales by geography ** Growth rates are expressed at constant exchange rates (CER). Growth rates in parentheses are expressed on a reported basis. Full-year 2022 company sales** €42,997m +7.0% (+13.9%) €8.26 +17.1% (+25.9%) * Earnings per share Full-year 2022 business EPS** €9,999m Europe €18,275m US €14,723m Rest of the World €16,457m Specialty Care €14,231m General Medicines €5,080m Consumer Healthcare €7,229m Vaccines Full-year 2022 results Latest regulatory milestones in Europe Microglia Approval of first and only treatment indicated for prurigo nodularis Approval of our next-generation booster vaccine for the prevention of COVID-19 in adults First approval worldwide of our new solution for the prevention of respiratory syncytial virus disease in infants Approval of new treatment for adult patients with cold agglutinin disease @Sanofi @Sanofi @Sanofi @SanofiaventisTVen

×